Evidence map›Paper›PMID 38599696›Full record

ArticleJACC. Cardiovascular interventions2024

Angiographic Coronary Slow Flow Is Not a Valid Surrogate for Invasively Diagnosed Coronary Microvascular Dysfunction.

Michael Mayer, Tess Allan, Kenneth L Harkin, Ethan Loftspring, Seyed E Saffari, Harmony R Reynolds, Jonathan Paul, Rohan Kalathiya, Atman P Shah, Sandeep Nathan and 4 more

Open access · greenAbstract read
In one paragraph

Article in JACC. Cardiovascular interventions, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Simple risk stratification for a complex coronary phenotype: association of the ACEF score with coronary slow flow.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Coronary Slow-Flow Syndrome: A Review on Natural History of Disease and Best Practices.Research in heart yield and translational medicine · 2025
    Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Michael MayerDepartment of Cardiology, University of Chicago, Chicago, Illinois, USA.
Tess AllanDepartment of Cardiology, University of Chicago, Chicago, Illinois, USA.
Kenneth L HarkinLeon H. Charney Division of Cardiology, Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA.
Ethan LoftspringLeon H. Charney Division of Cardiology, Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA.
Seyed E SaffariDepartment of Cardiology, University of Chicago, Chicago, Illinois, USA.
Harmony R ReynoldsLeon H. Charney Division of Cardiology, Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA.
Jonathan PaulDepartment of Cardiology, University of Chicago, Chicago, Illinois, USA.
Rohan KalathiyaDepartment of Cardiology, University of Chicago, Chicago, Illinois, USA.
Atman P ShahDepartment of Cardiology, University of Chicago, Chicago, Illinois, USA.
Sandeep NathanDepartment of Cardiology, University of Chicago, Chicago, Illinois, USA.
Mary C McCarthyDivision of Cardiology, Southlake Regional Health Centre, Newmarket, Ontario, Canada.
Nathaniel R SmilowitzLeon H. Charney Division of Cardiology, Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA; Cardiology Section, Department of Medicine, VA New York Harbor Healthcare System, New York, New York, USA.
Steven E S MinerDivision of Cardiology, Southlake Regional Health Centre, Newmarket, Ontario, Canada; School of Kinesiology and Health Science, York University, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
John BlairDepartment of Cardiology, University of Chicago, Chicago, Illinois, USA; Division of Cardiology, Department of Internal Medicine, University of Washington, Seattle, Washington, USA. Electronic address: jblair1@gmail.com.
University of Chicago · USNew York University · USSouthlake Regional Health Center · CAUniversity of Washington · US

Funding

Mechanisms of Coronary Microvascular DiseaseK23HL150315 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SMILOWITZ, NATHANIEL ROSSO · 2020 to 2024
$948k
NHLBI NIH HHS K23 HL150315
6 · The paper itself

Abstract

backgroundIschemia with no obstructive coronary arteries is frequently caused by coronary microvascular dysfunction (CMD). Consensus diagnostic criteria for CMD include baseline angiographic slow flow by corrected TIMI (Thrombolysis In Myocardial Infarction) frame count (cTFC), but correlations between slow flow and CMD measured by invasive coronary function testing (CFT) are uncertain.

objectivesThe aim of this study was to investigate relationships between cTFC and invasive CFT for CMD.

methodsAdults with ischemia with no obstructive coronary arteries underwent invasive CFT with thermodilution-derived baseline coronary blood flow, coronary flow reserve (CFR), and index of microcirculatory resistance (IMR). CMD was defined as abnormal CFR (<2.5) and/or abnormal IMR (≥25). cTFC was measured from baseline angiography; slow flow was defined as cTFC >25. Correlations between cTFC and baseline coronary flow and between CFR and IMR and associations between slow flow and invasive measures of CMD were evaluated, adjusted for covariates. All patients provided consent.

resultsAmong 508 adults, 49% had coronary slow flow. Patients with slow flow were more likely to have abnormal IMR (36% vs 26%; P = 0.019) but less likely to have abnormal CFR (28% vs 42%; P = 0.001), with no difference in CMD (46% vs 51%). cTFC was weakly correlated with baseline coronary blood flow (r = -0.35; 95% CI: -0.42 to -0.27), CFR (r = 0.20; 95% CI: 0.12 to 0.28), and IMR (r = 0.16; 95% CI: 0.07-0.24). In multivariable models, slow flow was associated with lower odds of abnormal CFR (adjusted OR: 0.53; 95% CI: 0.35 to 0.80).

conclusionsCoronary slow flow was weakly associated with results of invasive CFT and should not be used as a surrogate for the invasive diagnosis of CMD.

Indexed as

Coronary Artery DiseaseMyocardial InfarctionMyocardial IschemiaAdultCoronary AngiographyCoronary CirculationCoronary VesselsCysteineHumansMicrocirculationTreatment OutcomeVascular ResistanceCysteineS-(2-chloro-1,1,2-trifluoroethyl)cysteineanginacoronary angiographycoronary artery diseasemicrovascular angina

Identifiers

PMID38599696
PMCPMC11098671
OpenAlexW4394565573

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.